ARTÍCULO ORIGINAL
Análisis de la efectividad del tratamiento neoadyuvante al añadir docetaxel secuencial a fluorouracilo, epirrubicina y ciclofosfamida en pacientes con cáncer de mama avanzado: resultados preliminares de respuesta tumoral
Analysis of the efficacy of neoadjuvant treatment on adding preoperative sequential fluorouracil, epirubicin and cyclophosphamide in patients with advanced breast cancer: preliminary tumor response results
Nicolás Ramírez-Torresa,
, Christian Moctezuma-Mezaa, Juan Asbun-Bojalilb, Larissa Antonieta Valenzuela-Martínezc, Rosalia Victoria-Ayalac, Kenia Ortiz-Rodríguezc, María Eugenia Ayala-Anzuresc, Fidel Navarro-Muñozd, Germán Castelazo-Ricoa, Rosa María Patlán-Péreza, Gilberto Tena-Aláveze, Horacio Astudillo-de la Vegaf
Autor para correspondencia
nicolasestudio14@hotmail.com
Autor para correspondencia. Departamento de Ginecología Oncológica, UMAE del Hospital de Gineco-obstetricia N.° 3, Centro Médico Nacional La Raza, IMSS, México, D.F. Czda. Vallejo Esq. con Antonio Valeriano S/N, col. CP 07300, Ciudad de México, D.F., México. Tel.:éfono: +(525) 55 57245900, ext. 23 726.
Autor para correspondencia. Departamento de Ginecología Oncológica, UMAE del Hospital de Gineco-obstetricia N.° 3, Centro Médico Nacional La Raza, IMSS, México, D.F. Czda. Vallejo Esq. con Antonio Valeriano S/N, col. CP 07300, Ciudad de México, D.F., México. Tel.:éfono: +(525) 55 57245900, ext. 23 726.
a Servicio de Ginecología Oncológica, UMAE del Hospital de Ginecología y Obstetricia, N.Î 3, Centro Médico Nacional La Raza, IMSS, México, D.F., México
b Sección Posgrado, Escuela Superior de Medicina, IPN, México, D.F., México
c Servicio de Oncología Médica, UMAE del Hospital de Ginecología y Obstetricia, N.Î 3, Centro Médico Nacional La Raza, IMSS, México, D.F., México
d Servicio de Patología, UMAE del Hospital de Ginecología y Obstetricia, N.Î 3, Centro Médico Nacional La Raza, IMSS, México, D.F., México
e Director General de la UMAE del Hospital de Ginecología y Obstetricia, N.Î 3, Centro Médico Nacional La Raza, IMSS, México, D.F., México
f Laboratorio de Investigación Traslacional yTerapia Celular, Centro Médico Nacional SXXI, IMSS, México, D.F., México
Leído
5825
Vecesse ha leído el artículo
1340
Total PDF
4485
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 24 | 7 | 31 |
| 2025 11 | 62 | 24 | 86 |
| 2025 10 | 49 | 7 | 56 |
| 2025 9 | 56 | 12 | 68 |
| 2025 8 | 67 | 24 | 91 |
| 2025 7 | 70 | 7 | 77 |
| 2025 6 | 47 | 8 | 55 |
| 2025 5 | 37 | 2 | 39 |
| 2025 4 | 49 | 2 | 51 |
| 2025 3 | 54 | 8 | 62 |
| 2025 2 | 54 | 5 | 59 |
| 2025 1 | 67 | 5 | 72 |
| 2024 12 | 54 | 2 | 56 |
| 2024 11 | 81 | 8 | 89 |
| 2024 10 | 62 | 3 | 65 |
| 2024 9 | 70 | 6 | 76 |
| 2024 8 | 58 | 8 | 66 |
| 2024 7 | 84 | 7 | 91 |
| 2024 6 | 52 | 6 | 58 |
| 2024 5 | 62 | 7 | 69 |
| 2024 4 | 48 | 8 | 56 |
| 2024 3 | 57 | 4 | 61 |
| 2024 2 | 71 | 4 | 75 |
| 2024 1 | 71 | 7 | 78 |
| 2023 12 | 49 | 5 | 54 |
| 2023 11 | 64 | 6 | 70 |
| 2023 10 | 66 | 8 | 74 |
| 2023 9 | 60 | 0 | 60 |
| 2023 8 | 69 | 3 | 72 |
| 2023 7 | 84 | 4 | 88 |
| 2023 6 | 69 | 2 | 71 |
| 2023 5 | 90 | 3 | 93 |
| 2023 4 | 72 | 1 | 73 |
| 2023 3 | 59 | 1 | 60 |
| 2023 2 | 27 | 2 | 29 |
| 2022 1 | 33 | 1 | 34 |
| 2022 12 | 50 | 6 | 56 |
| 2022 11 | 52 | 5 | 57 |
| 2022 10 | 24 | 4 | 28 |
| 2022 9 | 21 | 8 | 29 |
| 2022 8 | 28 | 7 | 35 |
| 2022 7 | 16 | 8 | 24 |
| 2022 6 | 23 | 11 | 34 |
| 2022 5 | 30 | 4 | 34 |
| 2022 4 | 27 | 7 | 34 |
| 2022 3 | 39 | 5 | 44 |
| 2022 2 | 36 | 4 | 40 |
| 2021 1 | 68 | 5 | 73 |
| 2021 12 | 44 | 8 | 52 |
| 2021 11 | 45 | 9 | 54 |
| 2021 10 | 48 | 12 | 60 |
| 2021 9 | 35 | 12 | 47 |
| 2021 8 | 34 | 14 | 48 |
| 2021 7 | 31 | 5 | 36 |
| 2021 6 | 24 | 8 | 32 |
| 2021 5 | 39 | 4 | 43 |
| 2021 4 | 76 | 8 | 84 |
| 2021 3 | 73 | 12 | 85 |
| 2021 2 | 29 | 14 | 43 |
| 2020 1 | 40 | 13 | 53 |
| 2020 12 | 42 | 6 | 48 |
| 2020 11 | 39 | 8 | 47 |
| 2020 10 | 22 | 5 | 27 |
| 2020 9 | 22 | 17 | 39 |
| 2020 8 | 30 | 11 | 41 |
| 2020 7 | 16 | 6 | 22 |
| 2020 6 | 30 | 7 | 37 |
| 2020 5 | 28 | 9 | 37 |
| 2020 4 | 32 | 9 | 41 |
| 2020 3 | 38 | 10 | 48 |
| 2020 2 | 36 | 7 | 43 |
| 2020 1 | 18 | 4 | 22 |
| 2019 12 | 28 | 10 | 38 |
| 2019 11 | 23 | 6 | 29 |
| 2019 10 | 38 | 11 | 49 |
| 2019 9 | 27 | 11 | 38 |
| 2019 8 | 29 | 8 | 37 |
| 2019 7 | 34 | 24 | 58 |
| 2019 6 | 73 | 30 | 103 |
| 2019 5 | 162 | 24 | 186 |
| 2019 4 | 81 | 23 | 104 |
| 2019 3 | 23 | 15 | 38 |
| 2019 2 | 27 | 18 | 45 |
| 2019 1 | 11 | 4 | 15 |
| 2018 12 | 9 | 6 | 15 |
| 2018 11 | 13 | 11 | 24 |
| 2018 10 | 15 | 16 | 31 |
| 2018 9 | 21 | 4 | 25 |
| 2018 8 | 4 | 13 | 17 |
| 2018 7 | 4 | 2 | 6 |
| 2018 6 | 9 | 1 | 10 |
| 2018 5 | 11 | 11 | 22 |
| 2018 4 | 14 | 3 | 17 |
| 2018 3 | 7 | 1 | 8 |
| 2018 2 | 6 | 3 | 9 |
| 2018 1 | 5 | 0 | 5 |
| 2017 12 | 10 | 1 | 11 |
| 2017 11 | 8 | 3 | 11 |
| 2017 10 | 15 | 1 | 16 |
| 2017 9 | 12 | 7 | 19 |
| 2017 8 | 16 | 4 | 20 |
| 2017 7 | 12 | 0 | 12 |
| 2017 6 | 9 | 16 | 25 |
| 2017 5 | 14 | 9 | 23 |
| 2017 4 | 6 | 2 | 8 |
| 2017 3 | 9 | 21 | 30 |
| 2017 2 | 8 | 3 | 11 |
| 2016 1 | 8 | 3 | 11 |
| 2016 12 | 8 | 3 | 11 |
| 2016 11 | 9 | 2 | 11 |
| 2016 10 | 16 | 4 | 20 |
| 2016 9 | 7 | 1 | 8 |
| 2016 8 | 9 | 1 | 10 |
| 2016 7 | 8 | 15 | 23 |
| 2016 6 | 21 | 38 | 59 |
| 2016 5 | 9 | 38 | 47 |
| 2016 4 | 8 | 25 | 33 |
| 2016 3 | 18 | 28 | 46 |
| 2016 2 | 12 | 27 | 39 |
| 2015 1 | 11 | 19 | 30 |
| 2015 12 | 19 | 23 | 42 |
| 2015 11 | 18 | 17 | 35 |
| 2015 10 | 17 | 40 | 57 |
| 2015 9 | 21 | 43 | 64 |
| 2015 8 | 18 | 44 | 62 |
| 2015 7 | 9 | 53 | 62 |
| 2015 6 | 6 | 39 | 45 |
| 2015 5 | 7 | 46 | 53 |
Mostrar todo